DexTech Medical AB (XSAT:DEX) Volatility: 61.42% (As of Jun. 26, 2026)


XSAT:DEX DexTech Medical AB XSAT:DEX
32 GF Score
Price kr10.30
! 3 Warning Signs
View Full Analysis

What is DexTech Medical AB Volatility?

DexTech Medical AB XSAT:DEX 32 Volatility is 61.42% as of Jun. 26, 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-06-26), DexTech Medical AB's Volatility is 61.42%.

DexTech Medical AB  (XSAT:DEX) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

DexTech Medical AB Volatility Related Terms

XSAT:DEX vs VRTX, REGN, ALNY: Volatility Comparison

For the Biotechnology subindustry, DexTech Medical AB's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DexTech Medical AB Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Volatility distribution charts can be found below:

* The bar in red indicates where DexTech Medical AB's Volatility falls into.


XSAT:DEX
32GF Score
DexTech Medical AB XSAT:DEX
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexTech Medical AB  (XSAT:DEX) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 61.42% mean?
DexTech Medical AB (XSAT:DEX) has a Volatility of 61.42% as of Jun. 26, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on DexTech Medical AB and its competitors.
Is DexTech Medical AB's Volatility too high?
DexTech Medical AB's current Volatility is 61.42%. Overall, DexTech Medical AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's Volatility compare to VRTX and REGN?
DexTech Medical AB's Volatility of 61.42% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on DexTech Medical AB and its competitors. DexTech Medical AB's current Volatility is 61.42%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current Volatility of 61.42%. The current Volatility is 61.42%. DexTech Medical AB's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current Volatility is 61.42% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DexTech Medical AB Business Description

Address Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
32GF Score

Get the complete analysis for XSAT:DEX

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr10.30
Price